Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Sorin

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Frontiers in Physiology|November 8, 2021
Differential Regulation of the Asthmatic Phenotype by the Aryl Hydrocarbon ReceptorHussein Traboulsi, Angela Rico de Souza, Benoit Allard, et al.
Blood Advances|December 28, 2023
Risk of infectious adverse events of venetoclax therapy for hematologic malignancies: a systematic review and meta-analysis of RCTsConnor Prosty, Khaled Katergi, Alex Nguyen, et al.
Oncogene|May 14, 2024
Exploring the prognostic significance of arm-level copy number alterations in triple-negative breast cancerSamuel Doré, Mariam Ali, Mark Sorin, et al.
Annals of Thoracic Surgery Short Reports|January 10, 2025
Neoadjuvant Targeted Therapy in Non-Small Cell Lung Cancer and Its Impact on Surgical OutcomesMark Sorin, Caroline Huynh, Merav Rokah, et al.
Current Oncology (Toronto, Ont.)|November 26, 2025
Defining the Prognostic Significance of BRAF V600E in Early-Stage Colon Cancer: A Systematic Review and Meta-AnalysisMatthew Dankner, Laurie-Rose Dubé, Mark Sorin, et al.
Journal of Thoracic Disease|December 11, 2025
The effect of lobar versus sublobar video-assisted thoracoscopic surgery lung resection on patient quality of lifeLyndon C Walsh, Joseph Seitlinger, Morgan S Gold, et al.
Nature Communications|September 25, 2025
Oncogenic driver mutations underlie the spatial tumour immune landscape of non-small cell lung cancerSaskia Hartner, Hanie Abolfathi, Morteza Rezanejad, et al.
JAMA Oncology|March 21, 2024
Neoadjuvant Chemoimmunotherapy for NSCLC: A Systematic Review and Meta-AnalysisMark Sorin, Connor Prosty, Louis Ghaleb, et al.
Cancer Treatment and Research Communications|March 23, 2023
Next-generation sequencing of non-small cell lung cancer at a Quebec health care cancer centreMark Sorin, Sophie Camilleri-Broët, Emilie Pichette, et al.
Nature Communications|February 5, 2025
Spatially mapping the tumour immune microenvironments of non-small cell lung cancerLysanne Desharnais, Mark Sorin, Morteza Rezanejad, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Frontiers in Physiology|November 8, 2021
Differential Regulation of the Asthmatic Phenotype by the Aryl Hydrocarbon ReceptorHussein Traboulsi, Angela Rico de Souza, Benoit Allard, et al.
Blood Advances|December 28, 2023
Risk of infectious adverse events of venetoclax therapy for hematologic malignancies: a systematic review and meta-analysis of RCTsConnor Prosty, Khaled Katergi, Alex Nguyen, et al.
Oncogene|May 14, 2024
Exploring the prognostic significance of arm-level copy number alterations in triple-negative breast cancerSamuel Doré, Mariam Ali, Mark Sorin, et al.
Annals of Thoracic Surgery Short Reports|January 10, 2025
Neoadjuvant Targeted Therapy in Non-Small Cell Lung Cancer and Its Impact on Surgical OutcomesMark Sorin, Caroline Huynh, Merav Rokah, et al.
Current Oncology (Toronto, Ont.)|November 26, 2025
Defining the Prognostic Significance of BRAF V600E in Early-Stage Colon Cancer: A Systematic Review and Meta-AnalysisMatthew Dankner, Laurie-Rose Dubé, Mark Sorin, et al.
Journal of Thoracic Disease|December 11, 2025
The effect of lobar versus sublobar video-assisted thoracoscopic surgery lung resection on patient quality of lifeLyndon C Walsh, Joseph Seitlinger, Morgan S Gold, et al.
Nature Communications|September 25, 2025
Oncogenic driver mutations underlie the spatial tumour immune landscape of non-small cell lung cancerSaskia Hartner, Hanie Abolfathi, Morteza Rezanejad, et al.
JAMA Oncology|March 21, 2024
Neoadjuvant Chemoimmunotherapy for NSCLC: A Systematic Review and Meta-AnalysisMark Sorin, Connor Prosty, Louis Ghaleb, et al.
Cancer Treatment and Research Communications|March 23, 2023
Next-generation sequencing of non-small cell lung cancer at a Quebec health care cancer centreMark Sorin, Sophie Camilleri-Broët, Emilie Pichette, et al.
Nature Communications|February 5, 2025
Spatially mapping the tumour immune microenvironments of non-small cell lung cancerLysanne Desharnais, Mark Sorin, Morteza Rezanejad, et al.
Pageof 3